Bedossa P

Language: English
References: 7
Page: 450-451
PDF size: 113.20 Kb.

ABSTRACT

A 28-year-old female presented with upper quadrant abdominal pain. The patient did use oral contraceptives, her BMI was 35 kg/m^² and serum AFP level was within normal limit. A palpable liver mass was noted and CT demonstrated a pedonculated 10 cm tumor under the right liver lobe. A resection was performed.

REFERENCES

1. Nime F, Pickren JW, Vana J, Aronoff BL, Baker HW, Murphy GP. The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer 1979; 44: 1481-9.

2. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43: 515-24

3. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009; 50: 481-9.

4. Bluteau O, Jeannot E, Bioulac-Sage P, Marqués JM, Blanc JF, Bui H, Beaudoin JC, et al. Bi-allellic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32: 312-5.

5. Paradis V1, Champault A, Ronot M, Deschamps L, Valla DC, Vidaud D, Vilgrain V, et al. Telangiectatic adenomas: an entity associated with increased body mass index and inflammation. Hepatology 2007; 46:140-6.

6. Rebouissou S1, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumors. Nature 2009; 457: 2000-4.

7. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137: 1698-705.